BRPI0516314A - uso de hiv inteiro e método de tratamento de um indivìduo cronicamente infectado com hiv - Google Patents
uso de hiv inteiro e método de tratamento de um indivìduo cronicamente infectado com hivInfo
- Publication number
- BRPI0516314A BRPI0516314A BRPI0516314-5A BRPI0516314A BRPI0516314A BR PI0516314 A BRPI0516314 A BR PI0516314A BR PI0516314 A BRPI0516314 A BR PI0516314A BR PI0516314 A BRPI0516314 A BR PI0516314A
- Authority
- BR
- Brazil
- Prior art keywords
- hiv
- treatment
- whole
- infected individual
- chronically infected
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 abstract 4
- 230000024932 T cell mediated immunity Effects 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16061—Methods of inactivation or attenuation
- C12N2740/16063—Methods of inactivation or attenuation by chemical treatment
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
USO DE HIV INTEIRO E MéTODO DE TRATAMENTO DE UM INDIVìDUO CRONICAMENTE INFECTADO COM HIV. Um HIV inteiro inativado de um subtipo particular é utilizado para preparar vacinas e composições farmacêuticas que contêm vacinas. As vacinas podem ser usadas para tratar indivíduos cronicamente infectados com HIV, por indução de uma resposta imune celular protetora nos indivíduos contra o mesmo subtipo HIV usado para produzir a vacina.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61572904P | 2004-10-04 | 2004-10-04 | |
PCT/IB2005/003384 WO2006038124A1 (en) | 2004-10-04 | 2005-10-04 | Subtype-matched inactivated whole virus vaccines for treating patients with hiv infection |
US11/243,094 US20060093623A1 (en) | 2004-10-04 | 2005-10-04 | Subtype-matched inactivated whole virus vaccines for treating patients with HIV infection |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0516314A true BRPI0516314A (pt) | 2008-09-02 |
Family
ID=35695555
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0516314-5A BRPI0516314A (pt) | 2004-10-04 | 2005-10-04 | uso de hiv inteiro e método de tratamento de um indivìduo cronicamente infectado com hiv |
Country Status (14)
Country | Link |
---|---|
US (1) | US20060093623A1 (pt) |
EP (1) | EP1797175B1 (pt) |
JP (1) | JP2008515795A (pt) |
CN (1) | CN101056977B (pt) |
AT (1) | ATE401392T1 (pt) |
AU (1) | AU2005290930B2 (pt) |
BR (1) | BRPI0516314A (pt) |
CA (1) | CA2582426A1 (pt) |
DE (1) | DE602005008264D1 (pt) |
ES (1) | ES2310848T3 (pt) |
IL (1) | IL182440A (pt) |
MX (1) | MX2007004028A (pt) |
RU (1) | RU2396346C2 (pt) |
WO (1) | WO2006038124A1 (pt) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2558933T3 (es) | 2009-01-29 | 2016-02-09 | Michel Vandevelde | Composición de vacuna a base de un virus que presenta una proteína con uno o varios restos de dedo de zinc, su procedimiento de preparación y su utilización |
WO2010096831A1 (en) * | 2009-02-23 | 2010-08-26 | Candace Pert | Rapid infectious virus assay |
SG194079A1 (en) * | 2011-04-06 | 2013-11-29 | Biovaxim Ltd | Pharmaceutical compositions for preventing and/or treating an hiv disease in humans |
EP2819696A1 (en) * | 2012-03-02 | 2015-01-07 | Laboratorios Del. Dr. Esteve, S.A. | Method for the preparation of dendritic cell vaccines |
EP2821082A1 (en) * | 2013-07-05 | 2015-01-07 | Laboratoire Biodim | Method of producing an inactivated lentivirus, especially HIV, vaccine, kit and method of use |
AU2018266705B2 (en) | 2017-05-08 | 2023-05-04 | Gritstone Bio, Inc. | Alphavirus neoantigen vectors |
BR122024002387A2 (pt) | 2019-05-30 | 2024-03-12 | Gritstone Bio, Inc. | Vetores de adenovírus, composição farmacêutica, sequência de nucleotídeo isolada, célula isolada, vetor, kit, usos de um vetor, método para fabricar o vetor, métodos para produzir um vírus e vetor viral |
CA3145833A1 (en) * | 2019-07-02 | 2021-01-07 | Roman YELENSKY | Hiv antigens and mhc complexes |
AU2021320896A1 (en) | 2020-08-06 | 2023-03-23 | Gritstone Bio, Inc. | Multiepitope vaccine cassettes |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE365206T1 (de) * | 1998-02-13 | 2007-07-15 | Adan Rios | Verfahren zur entwicklung von einem hiv impfstoff |
US6828460B2 (en) * | 1999-03-22 | 2004-12-07 | Pfizer Inc. | Resorcinol derivatives |
CA2397998A1 (en) * | 2000-01-28 | 2001-08-02 | Statens Serum Institut | Hiv peptides and nucleic acids encoding them for diagnosis and control of hiv infection |
US20040236093A1 (en) * | 2001-02-27 | 2004-11-25 | Olivier Schwartz | Mhc-i-restricted presentation of hiv-1 virion antigens without viral replication. application to the stimulation of ctl and vaccination in vivo; analysis of vaccinating composition in vitro |
EP1490396A4 (en) * | 2001-03-01 | 2006-04-19 | Us Gov Health & Human Serv | IMMUNOGENIC HIV PEPTIDES AS REAGENTS AND AS VACCINES |
US7566568B2 (en) * | 2001-04-27 | 2009-07-28 | Istituto Superiore Di Sanita | Method for generating highly active human dendritic cells from peripheral blood mononuclear cells |
US20040009194A1 (en) * | 2002-06-21 | 2004-01-15 | Jean-Marie Andrieu | Methods, and compositions for a therapeutic antigen presenting cell vaccine for treatment of immunodeficiency virus |
US20040109876A1 (en) * | 2002-11-25 | 2004-06-10 | Kureha Chemical Industry Co., Ltd. | Vaccine composition, HIV-infection suppression factor and method for the vaccination against HIV |
EP1567014B1 (en) * | 2002-12-04 | 2011-09-28 | Baylor Research Institute | Rapid one-step method for generation of antigen loaded dendritic cell vaccine from precursors |
US7786288B2 (en) * | 2003-10-23 | 2010-08-31 | Karp Nelson M | Immunizing compositions encoding an epitope obtained from the HIV-1 capsid protein cyclophilin A binding site |
-
2005
- 2005-10-04 CA CA002582426A patent/CA2582426A1/en not_active Abandoned
- 2005-10-04 AT AT05798981T patent/ATE401392T1/de not_active IP Right Cessation
- 2005-10-04 JP JP2007534112A patent/JP2008515795A/ja active Pending
- 2005-10-04 BR BRPI0516314-5A patent/BRPI0516314A/pt not_active IP Right Cessation
- 2005-10-04 AU AU2005290930A patent/AU2005290930B2/en not_active Ceased
- 2005-10-04 CN CN2005800337813A patent/CN101056977B/zh not_active Expired - Fee Related
- 2005-10-04 US US11/243,094 patent/US20060093623A1/en not_active Abandoned
- 2005-10-04 MX MX2007004028A patent/MX2007004028A/es active IP Right Grant
- 2005-10-04 RU RU2007115549/13A patent/RU2396346C2/ru not_active IP Right Cessation
- 2005-10-04 DE DE602005008264T patent/DE602005008264D1/de active Active
- 2005-10-04 EP EP05798981A patent/EP1797175B1/en not_active Not-in-force
- 2005-10-04 ES ES05798981T patent/ES2310848T3/es active Active
- 2005-10-04 WO PCT/IB2005/003384 patent/WO2006038124A1/en active IP Right Grant
-
2007
- 2007-04-10 IL IL182440A patent/IL182440A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE602005008264D1 (de) | 2008-08-28 |
CN101056977A (zh) | 2007-10-17 |
RU2007115549A (ru) | 2008-11-10 |
EP1797175B1 (en) | 2008-07-16 |
JP2008515795A (ja) | 2008-05-15 |
ATE401392T1 (de) | 2008-08-15 |
IL182440A (en) | 2011-01-31 |
CA2582426A1 (en) | 2006-04-13 |
AU2005290930B2 (en) | 2010-12-16 |
MX2007004028A (es) | 2007-09-11 |
AU2005290930A1 (en) | 2006-04-13 |
EP1797175A1 (en) | 2007-06-20 |
US20060093623A1 (en) | 2006-05-04 |
IL182440A0 (en) | 2007-07-24 |
ES2310848T3 (es) | 2009-01-16 |
WO2006038124A1 (en) | 2006-04-13 |
RU2396346C2 (ru) | 2010-08-10 |
CN101056977B (zh) | 2013-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0516314A (pt) | uso de hiv inteiro e método de tratamento de um indivìduo cronicamente infectado com hiv | |
UY39060A (es) | Composiciones y métodos para prevenir y tratar la infección por coronavirus - vacunas sars-cov-2 | |
BR112018016755A2 (pt) | vacina contra o vírus da zica | |
BR112018011122A2 (pt) | antígenos, vetores, composições, e métodos de utilização para o vírus da imunodeficiência humana dos mesmos | |
BR112013009649A2 (pt) | composição imunogênica, métodos para provocar uma resposta imune protetora em um paciente humano e para fornecer proteção imune em seres humanos contra doença, e, uso de uma composição | |
DE60330708D1 (de) | Impfstoff gegen das west-nile-virus | |
BR112013032251A2 (pt) | composição estável da vacina da cepa do vírus chikungunya inativado com uma ou mais mutações; método para induzir uma resposta imune protetora em indivíduos humanos contra infecções causadas pelo vírus chikungunya; uso de isolados do vírus chikungunya; composição combinada da vacina | |
BR0107972A (pt) | Uso de uma proteìna ou polinucleotìdeo tat do hiv, nef do hiv, ou tat do hiv ligado(a) a uma proteìna ou polinucleotìdeo nef do hiv (nef-tat), e de uma proteìna ou polinucleotìdeo gp120 do hiv, método para imunizar um ser humano contra o hiv, e, composição de vacina para o uso humano | |
BRPI0511776A (pt) | vìrus atenuado de influenza de suìnos, formulação imunogênica, formulação farmacêutica, métodos para imunizar ou induzir uma resposta imune em um porco, para tratar uma infecção por vìrus de influenza de suìnos em um porco, para tratar cáncer em um porco, e para produzir uma formulação imunogênica, célula, linhagem de células de porco, e, ovo embrionado | |
PE20151588A1 (es) | Vacuna contra el virus del dengue | |
AR052165A1 (es) | Tratamiento de hepatitis c en la poblacion asiatica | |
BR112015022582A2 (pt) | molécula de ácido nucleico, plasmídeo, vacina, e, uso de um plasmídeo | |
ATE458496T1 (de) | Hiv-vakzine und anwendungsverfahren | |
BR112015017966A2 (pt) | composições imunogênicas compreendendo vírus silificado e métodos de uso | |
UY36394A (es) | Vacunas contra la enfermedad de manos, pies y boca y métodos de fabricación y su uso. | |
BR112022022859A2 (pt) | Vacinas contra sars-cov-2 | |
AR042530A1 (es) | Vacuna que comprende particulas viroides del virus papiloma humano 16 y 18 | |
BR112016002354A2 (pt) | composição imunogênica, métodos para proteger um bebê contra infecção ou doença e para evocar uma resposta imune, regime de vacinação, e, kit | |
BR112015031226A2 (pt) | Composição de vacina, e, uso da composição de vacina | |
BRPI0514884A (pt) | composição vacinal para gerar resposta imune celular e humoral protetora contra a infecção pelo vìrus de hepatite c | |
AR054259A1 (es) | Vacuna contra virus de papiloma humano (hpv) | |
BR112013001946A2 (pt) | vírus varicela zoster inativado, composição farmacêutica, método para preparar um vírus varicela zoster inativado, vacina, e, método para o tratamento de herpes zoster em um indivíduo | |
AR039982A1 (es) | Composicion vacunal contra las alergias, metodo para su obtencion y empleo en el tratamiento de las mismas | |
AR106057A1 (es) | Composición con efecto antiviral, composición farmacéutica | |
AR115070A1 (es) | Células madre que comprenden un virus vacuna quimérico sintético y métodos para su uso |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 8A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2260 DE 29/04/2014. |